Arsène Stéphanie, Leclercq Roland
CHU de Caen, Service de Microbiologie, avenue Côte de Nacre, 14033 Caen cedex, France.
Antimicrob Agents Chemother. 2007 Sep;51(9):3254-8. doi: 10.1128/AAC.00274-07. Epub 2007 Jul 9.
Fluoroquinolones are poorly active against enterococci. Recently, plasmid-borne resistance to fluoroquinolones due to the qnr gene was reported in members of the Enterobacteriaceae family. The gene encodes a pentapeptide repeat protein that protects DNA gyrase from inhibition by fluoroquinolones. We have identified in the genome of Enterococcus faecalis V583 a qnr-like gene, named E. faecalis qnr (qnr(E. faecalis)), encoding a putative pentapeptide repeat protein that shares 25% identity with Qnr. To assess its potential role in the intrinsic resistance of E. faecalis to fluoroquinolones, qnr(E. faecalis) was inactivated in E. faecalis JH2-2 by insertion of the thermosensitive vector pG1KT. This strain was then complemented with qnr(E. faecalis) cloned in the multicopy plasmid pORI23. The effects of its overexpression were also studied. Inactivation of the qnr(E. faecalis) gene resulted in twofold decreases in the MICs of ofloxacin and ciprofloxacin. When the gene was complemented or overexpressed, MICs of fluoroquinolones increased four- to nine-fold, leading to MICs of ofloxacin and ciprofloxacin equal to 32 mug/ml and 8 mug/ml, respectively. The E. faecalis Qnr (Qnr(E. faecalis)) protein was produced and purified. Qnr(E. faecalis) protein protected Escherichia coli DNA gyrase from inhibition by ofloxacin. The qnr(E. faecalis) gene was then introduced into E. coli DH10B, Staphylococcus aureus RN4220, and Lactococcus lactis IL-1419 to study its heterologous expression. MICs of the various fluoroquinolones tested increased 4- to 16-fold, showing that Qnr(E. faecalis) conferred resistance to fluoroquinolones in various bacterial backgrounds. Overexpression of qnr(E. faecalis) in enterococci or mobilization of the gene to other bacterial species may be anticipated as a possible new mechanism for fluoroquinolone resistance.
氟喹诺酮类药物对肠球菌的活性较差。最近,在肠杆菌科成员中报道了由于qnr基因导致的对氟喹诺酮类药物的质粒介导耐药性。该基因编码一种五肽重复蛋白,可保护DNA回旋酶免受氟喹诺酮类药物的抑制。我们在粪肠球菌V583的基因组中鉴定出一个qnr样基因,命名为粪肠球菌qnr(qnr(E. faecalis)),它编码一种假定的五肽重复蛋白,与Qnr有25%的同源性。为了评估其在粪肠球菌对氟喹诺酮类药物固有耐药性中的潜在作用,通过插入温度敏感载体pG1KT使粪肠球菌JH2-2中的qnr(E. faecalis)失活。然后用克隆在多拷贝质粒pORI23中的qnr(E. faecalis)对该菌株进行互补。还研究了其过表达的影响。qnr(E. faecalis)基因的失活导致氧氟沙星和环丙沙星的最低抑菌浓度(MIC)降低了两倍。当该基因被互补或过表达时,氟喹诺酮类药物的MIC增加了4至9倍,导致氧氟沙星和环丙沙星的MIC分别等于32μg/ml和8μg/ml。粪肠球菌Qnr(Qnr(E. faecalis))蛋白被产生并纯化。Qnr(E. faecalis)蛋白保护大肠杆菌DNA回旋酶免受氧氟沙星的抑制。然后将qnr(E. faecalis)基因导入大肠杆菌DH10B、金黄色葡萄球菌RN4220和乳酸乳球菌IL-1419中以研究其异源表达。所测试的各种氟喹诺酮类药物的MIC增加了4至16倍,表明Qnr(E. faecalis)在各种细菌背景中赋予了对氟喹诺酮类药物的耐药性。粪肠球菌中qnr(E. faecalis)的过表达或该基因向其他细菌物种的转移可能被认为是氟喹诺酮类药物耐药性的一种可能的新机制。